Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations.

PubWeight™: 2.28‹?› | Rank: Top 2%

🔗 View Article (PMID 20520575)

Published in J Hypertens on October 01, 2010

Authors

Hong-Qi Fan1, Yan Li, Lutgarde Thijs, Tine W Hansen, José Boggia, Masahiro Kikuya, Kristina Björklund-Bodegård, Tom Richart, Takayoshi Ohkubo, Jørgen Jeppesen, Christian Torp-Pedersen, Eamon Dolan, Tatiana Kuznetsova, Katarzyna Stolarz-Skrzypek, Valérie Tikhonoff, Sofia Malyutina, Edoardo Casiglia, Yuri Nikitin, Lars Lind, Edgardo Sandoya, Kalina Kawecka-Jaszcz, Yutaka Imai, Hans Ibsen, Eoin O'Brien, Jiguang Wang, Jan A Staessen, International Database on Ambulatory Blood Pressure In Relation to Cardiovascular Outcomes Investigators

Author Affiliations

1: Center for Epidemiological Studies and Clinical Trials, and Center for Vascular Evaluations, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Associated clinical trials:

Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern | NCT03603938

The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD | NCT03604003

Articles citing this

Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol (2011) 3.43

Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care (2011) 2.11

Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study. Am J Hypertens (2012) 2.01

Pro: Ambulatory blood pressure should be used in all patients on hemodialysis. Nephrol Dial Transplant (2015) 1.72

Update: ambulatory blood pressure monitoring in children and adolescents: a scientific statement from the American Heart Association. Hypertension (2014) 1.55

Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data. Clin Hypertens (2016) 1.40

Racial differences in abnormal ambulatory blood pressure monitoring measures: Results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Hypertens (2014) 1.04

Chronotherapy improves blood pressure control and reduces vascular risk in CKD. Nat Rev Nephrol (2013) 0.97

Correlates of isolated nocturnal hypertension and target organ damage in a population-based cohort of African Americans: the Jackson Heart Study. Am J Hypertens (2013) 0.92

Evaluation of Criteria to Detect Masked Hypertension. J Clin Hypertens (Greenwich) (2016) 0.89

A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease. Hypertension (2012) 0.86

High prevalence of isolated nocturnal hypertension in Chinese patients with chronic kidney disease. J Am Heart Assoc (2015) 0.83

Is Isolated Nocturnal Hypertension A Reproducible Phenotype? Am J Hypertens (2015) 0.82

Management of Resistant Hypertension: Do Not Give Up on Medication. Nephrol Self Assess Program (2014) 0.81

The use of ambulatory blood pressure monitoring among Medicare beneficiaries in 2007-2010. J Am Soc Hypertens (2014) 0.81

Recognition and Management of Resistant Hypertension. Clin J Am Soc Nephrol (2016) 0.80

Investigation on cardiovascular risk prediction using physiological parameters. Comput Math Methods Med (2013) 0.79

Isolated nocturnal hypertension and subclinical target organ damage: a systematic review of the literature. Hypertens Res (2015) 0.78

Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension? Clin Exp Nephrol (2015) 0.78

The complex relationship between CKD and ambulatory blood pressure patterns. Adv Chronic Kidney Dis (2015) 0.77

Estimate of nocturnal blood pressure and detection of non-dippers based on clinical or ambulatory monitoring in the inpatient setting. BMC Cardiovasc Disord (2013) 0.77

Systolic blood pressure and outcomes in stage 3-4 chronic kidney disease patients: evidence from a Taiwanese cohort. Am J Hypertens (2014) 0.77

Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: Improving the Detection of Hypertension study. J Hypertens (2016) 0.76

Current issues in the management and monitoring of hypertension in chronic kidney disease. Curr Opin Nephrol Hypertens (2013) 0.76

Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis. Nat Rev Nephrol (2016) 0.76

Endothelial function in postmenopausal women with nighttime systolic hypertension. Menopause (2015) 0.76

Endocan and Non-Dipping Circadian Pattern in Newly Diagnosed Essential Hypertension. Korean Circ J (2016) 0.75

Nocturnal Non-dipping Blood Pressure Profile in Black Normotensives Is Associated with Cardiac Target Organ Damage. Ethn Dis (2016) 0.75

Ambulatory Blood Pressure Monitoring: Five Decades of More Light and Less Shadows. Arq Bras Cardiol (2016) 0.75

Relationship between nocturnal blood pressure and 24-h urinary sodium excretion in a rural population in Korea. Clin Hypertens (2014) 0.75

Introduction to the American Heart Association's Hypertension Strategically Focused Research Network. Hypertension (2016) 0.75

Hydrochlorothiazide is not the most useful nor versatile thiazide diuretic. Curr Opin Cardiol (2015) 0.75

The platelet-to-lymphocyte ratio as an inflammation marker in non-dipper hypertensive patients. Hippokratia (2016) 0.75

Prognostic Effect of Isolated Nocturnal Hypertension in Chinese Patients With Nondialysis Chronic Kidney Disease. J Am Heart Assoc (2016) 0.75

Ambulatory blood pressure monitoring: its time to move on! J Hypertens (2010) 0.75

Articles by these authors

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 23.18

Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09

Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature (2012) 18.23

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet (2003) 17.34

The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68

Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA (2003) 16.08

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet (2005) 12.92

Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med (2013) 11.10

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Genome-wide association study of 107 phenotypes in Arabidopsis thaliana inbred lines. Nature (2010) 10.66

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet (2003) 9.80

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43

Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93

Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA (2011) 8.83

Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med (2009) 8.51

Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet (2010) 8.39

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

Modelling schizophrenia using human induced pluripotent stem cells. Nature (2011) 7.41

Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation (2006) 7.01

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet (2002) 6.87

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. Lancet (2012) 6.78

A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A (2012) 6.27

Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet (2009) 6.25

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ (2011) 5.84

Trends in survival after in-hospital cardiac arrest. N Engl J Med (2012) 5.67

Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis (2002) 5.64

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med (2003) 5.45

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res (2009) 5.24

Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (2007) 5.21

A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature (2013) 5.18

Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension (2005) 5.05

Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study. Circulation (2011) 4.90

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res (2014) 4.83

Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation (2009) 4.78

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (2012) 4.75

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science (2006) 4.71

Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med (2012) 4.69

Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens (2002) 4.63

Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med (2003) 4.59

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med (2010) 4.52

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37

Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis (2004) 4.29

European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28

A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil (2003) 4.25

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol (2011) 4.16

Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data. Lancet (2012) 4.16

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

New world bats harbor diverse influenza A viruses. PLoS Pathog (2013) 4.10

Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit (2002) 4.02

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med (2010) 4.01

Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol (2010) 3.93

Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91